Amicus Therapeutics Q2 Adj. EPS $0.01 Beats $(0.11) Estimate, Sales $154.688M Beat $147.399M Estimate

Amicus Therapeutics (NASDAQ: FOLD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.11) by 109.09 percent. This is a 83.33 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $154.688 million which beat the analyst consensus estimate of $147.399 million by 4.94 percent. This is a 22.12 percent increase over sales of $126.669 million the same period last year.